Main HAll - 2021
«
Prev
1
/
3
Next
»


25 Nashwa Saeed Inceptor, a promising target for diabetes management

24 Amr El Meligy Epicardial adipose tissue an emerging biomarker in CVD

20 Nabil El Kafrawy Semaglutide once weekly Above & Beyond

19 Ibrahim Elebrashy IDegLira The Power of DUAL action

17 Salah Shelbaya Liraglutide 3 0 mg filling the gap in obesity management

12 Nabil El Naggar Multi receptor agonist for management of

11 Nabil El Kafrawy Novel Dual GIP GLP 1 receptor agonists

10 Nermine Sheriba SGLT 2 and DPP 4 inhibitors A complementary mechanism of action

08 Salah Shelbaya State of the art lecture Metformin beyond glycemic control

06 Magdy Helmy Megalla Enriching T2DM patients control

05 Ibrahim Elebrashy VERIFY updates The value of numbers!

04 Opening Ceremony

03 Ahmed Bahaa Evidence based guidelines for diabetic kidney disease

02 Inas Sabry Continuous glucose monitoring in diabetes

01 Salwa Seddik Hosny Trials of oral therapy for type 1 diabetes
«
Prev
1
/
3
Next
»
